Smartlab Europe

News

EU Commission Pays Serious Heed To Critical Drug Shortages

The European Commission has gone on to take steps so as to tackle the issue of critical medicine shortages. These actions include putting up a unified strategy when it comes to stockpiling drugs and establishing a shortage alert system...

Pharma Giants And The Curious Case of Antitrust Lawsuits

Although one must have heard of tech giants such as Microsoft, Apple, as well as Meta getting caught up in certain antitrust scandals, big pharma is no less involved when it comes to antitrust litigation. Tactics such as pay-for-delay...

Astellas & Pfizer Settle Their Lawsuit Against Sun Pharma

As per findings pertaining to court filings, Astellas Pharma Inc. and Pfizer Inc. have gone on to reach a settlement in their lawsuit against Sun Pharmaceutical Industries Ltd. with regards to the production of a generic variant of the...

CPHI selects 2023 Pharma Award winners

CPHI Barcelona announces the winners of the prestigious 2023 CPHI Pharma Awards. The awards recognise outstanding achievements and contributions from the global pharma industry and supply chain across 12 wide-ranging categories. Enrico Zodio, CEO of Procos, stood out as the clear...

DuPont introduces conductive tape for use as dry electrode in biosignal monitoring

DuPont announced that it is introducing DuPont™ Liveo™ Soft Skin Conductive Tape 1-3150 – a silicone-based thermoset adhesive for electrical biosignal sensing and transfer. Combining the key benefits of silicone technology with electrically conductive properties, Liveo™ Soft Skin Conductive Tape...

Phastar Offers Pro Bono Support to Medicines Development for Global Health

Phastar, a global specialist biometrics contract research organization (CRO), is offering pro bono support to Medicines Development for Global Health (MDGH), a not-for-profit organization developing medicines for neglected diseases primarily affecting people living in low- and middle-income countries. As part...

Samsung Biologics and Kurma Partners announce strategic partnership for development and manufacturing of biologics for Kurmas portfolio companies

Samsung Biologics to provide de-risking, development, manufacturing services, and seamless transitions for biologics from early stages of development to large-scale commercialization The partnership will streamline gene to IND process to accelerate lead candidate selection and advance CMC along clinical development Multi-year...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »